146 related articles for article (PubMed ID: 35939992)
1. Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.
Wei J; Wang H; Zheng Q; Zhang J; Chen Z; Wang J; Ouyang L; Wang Y
Eur J Med Chem; 2022 Nov; 241():114650. PubMed ID: 35939992
[TBL] [Abstract][Full Text] [Related]
2. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of SENP1 in tumorigenesis and cancer therapy.
Lin M; Zhang M; Yi B; Chen J; Wen S; Chen R; Chen T; Li Z
Front Pharmacol; 2024; 15():1354323. PubMed ID: 38389923
[TBL] [Abstract][Full Text] [Related]
4. The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.
Rodríguez-Castañeda F; Lemma RB; Cuervo I; Bengtsen M; Moen LM; Ledsaak M; Eskeland R; Gabrielsen OS
J Biol Chem; 2018 Oct; 293(40):15439-15454. PubMed ID: 30082317
[TBL] [Abstract][Full Text] [Related]
5. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Class of Potent and Selective Non-competitive Sentrin-Specific Protease 1 Inhibitors.
Lindenmann U; Brand M; Gall F; Frasson D; Hunziker L; Kroslakova I; Sievers M; Riedl R
ChemMedChem; 2020 Apr; 15(8):675-679. PubMed ID: 32083799
[TBL] [Abstract][Full Text] [Related]
7. The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing.
Shen LN; Dong C; Liu H; Naismith JH; Hay RT
Biochem J; 2006 Jul; 397(2):279-88. PubMed ID: 16553580
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of sentrinized proteins by a novel sentrin-specific protease.
Gong L; Millas S; Maul GG; Yeh ET
J Biol Chem; 2000 Feb; 275(5):3355-9. PubMed ID: 10652325
[TBL] [Abstract][Full Text] [Related]
9. [SENP1 induced protein deSUMO modification increased the chemotherapy sensitivity of endometrial cancer side population cells].
Yuan ML; Bai J; Li CY; Xue N; Chen XH; Sheng F; Liu XZ; Li P
Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1362-1368. PubMed ID: 36575788
[No Abstract] [Full Text] [Related]
10. SENP1 participates in Irinotecan resistance in human colon cancer cells.
Chen MC; Nhan DC; Hsu CH; Wang TF; Li CC; Ho TJ; Mahalakshmi B; Chen MC; Yang LY; Huang CY
J Cell Biochem; 2021 Oct; 122(10):1277-1294. PubMed ID: 34037277
[TBL] [Abstract][Full Text] [Related]
11. The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
Chauhan KM; Chen Y; Chen Y; Liu AT; Sun XX; Dai MS
J Cell Biochem; 2021 Feb; 122(2):189-197. PubMed ID: 32786121
[TBL] [Abstract][Full Text] [Related]
12. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms.
Bawa-Khalfe T; Cheng J; Lin SH; Ittmann MM; Yeh ET
J Biol Chem; 2010 Aug; 285(33):25859-66. PubMed ID: 20551310
[TBL] [Abstract][Full Text] [Related]
13. Noncovalent structure of SENP1 in complex with SUMO2.
Ambaye ND
Acta Crystallogr F Struct Biol Commun; 2019 May; 75(Pt 5):332-339. PubMed ID: 31045562
[TBL] [Abstract][Full Text] [Related]
14. SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
Sun XX; Chen Y; Su Y; Wang X; Chauhan KM; Liang J; Daniel CJ; Sears RC; Dai MS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):10983-10988. PubMed ID: 30305424
[TBL] [Abstract][Full Text] [Related]
15. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1.
Kim YH; Sung KS; Lee SJ; Kim YO; Choi CY; Kim Y
FEBS Lett; 2005 Nov; 579(27):6272-8. PubMed ID: 16253240
[TBL] [Abstract][Full Text] [Related]
16. SENP1 regulates PTEN stability to dictate prostate cancer development.
Bawa-Khalfe T; Yang FM; Ritho J; Lin HK; Cheng J; Yeh ET
Oncotarget; 2017 Mar; 8(11):17651-17664. PubMed ID: 27852060
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Dual SENP1 and SENP2 Inhibitor.
Brand M; Bommeli EB; Rütimann M; Lindenmann U; Riedl R
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292935
[TBL] [Abstract][Full Text] [Related]
18. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells.
Bawa-Khalfe T; Cheng J; Wang Z; Yeh ET
J Biol Chem; 2007 Dec; 282(52):37341-9. PubMed ID: 17932034
[TBL] [Abstract][Full Text] [Related]
19. Identification of SENP1 inhibitors through in silico screening and rational drug design.
Zhao Y; Wang Z; Zhang J; Zhou H
Eur J Med Chem; 2016 Oct; 122():178-184. PubMed ID: 27344494
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the SENP1 mutant C603S-SUMO complex reveals the hydrolytic mechanism of SUMO-specific protease.
Xu Z; Chau SF; Lam KH; Chan HY; Ng TB; Au SW
Biochem J; 2006 Sep; 398(3):345-52. PubMed ID: 16712526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
